
feed2js_ck = true;

document.write('<div class="rss-box">');
document.write('<p class="rss-title"><a class="rss-title" href="https://www.law360.com/classaction?utm_source=rss&utm_medium=rss&utm_campaign=section" target="_self">Law360: Class Action</a><br /><span class="rss-item">Latest articles for: Class Action</span></p>');
document.write('<ul class="rss-items">');
document.write('<li class="rss-item"><a class="rss-item" href="https://www.law360.com/classaction/articles/1228276?utm_source=rss&utm_medium=rss&utm_campaign=section" target="_self">USC Workers Urge Cert. Of Massive Class In ERISA Row</a><br />');
document.write('An attorney for current and former University of Southern California workers urged a California federal judge at a hearing Friday to certify a class of tens of thousands of workers accusing the school of mismanaging their retirement savings, while USC argued there are too many individual differences to proceed classwide.');
document.write('</li>');
document.write('<li class="rss-item"><a class="rss-item" href="https://www.law360.com/classaction/articles/1228165?utm_source=rss&utm_medium=rss&utm_campaign=section" target="_self">Another Investor Says Canopy Skewed Canadian Pot Demand</a><br />');
document.write('Canopy Growth has been hit with another proposed securities class action, this time by investors represented by Pomerantz LLP, accusing the cannabis behemoth of misrepresenting the size of the Canadian pot market.');
document.write('</li>');
document.write('<li class="rss-item"><a class="rss-item" href="https://www.law360.com/classaction/articles/1228305?utm_source=rss&utm_medium=rss&utm_campaign=section" target="_self">Endo\'s $82.5M Deal In Suit Over Opioid Drug Gets Final OK</a><br />');
document.write('An $82.5 million cash deal ending investors\' claims that pharmaceutical company Endo International PLC hid safety issues with an opioid drug was finalized in Pennsylvania federal court Friday.');
document.write('</li>');
document.write('</ul></div>');
